Artwork

İçerik Xtelligent Healthcare Media tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Xtelligent Healthcare Media veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

Regulating and monitoring the online GLP-1 market

23:47
 
Paylaş
 

Manage episode 454612123 series 2797294
İçerik Xtelligent Healthcare Media tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Xtelligent Healthcare Media veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

GLP-1 (glucagon-like peptide 1) medications are revolutionizing weight loss and diabetes care, but behind the hype lies a growing web of regulatory gaps, telehealth expansion and online pharmacy risks. This episode unpacks the opportunities -- and dangers -- shaping the future of these life-changing drugs.

Featuring: Scott Roth, Chief Executive Officer, LegitScript

Gerard Olsen, Director of Research, LegitScript

In today’s episode, we'll cover…

  • The skyrocketing demand for GLP-1 medications and their influence on weight loss trends, including a 26% drop in bariatric surgeries
  • How telehealth and online pharmacies are reshaping access to GLP-1 drugs -- and the risks posed by rogue sellers and counterfeit products
  • The critical need for stronger regulatory enforcement and LegitScript's role in ensuring safety and transparency in the online healthcare market

To learn more about GLP-1 medications from all angles, check out our Pharma Life Sciences, Patient Engagement and Healthcare Payers sites.

To watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Metabolic bariatric surgery in the GLP-1 era (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825349)

Risks of online semaglutide without prescription (https://www.techtarget.com/pharmalifesciences/news/366609735/Study-uncovers-risks-of-buying-semaglutide-online)

FDA updates on GLP-1 compounding policies (https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize)

  continue reading

121 bölüm

Artwork
iconPaylaş
 
Manage episode 454612123 series 2797294
İçerik Xtelligent Healthcare Media tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Xtelligent Healthcare Media veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

GLP-1 (glucagon-like peptide 1) medications are revolutionizing weight loss and diabetes care, but behind the hype lies a growing web of regulatory gaps, telehealth expansion and online pharmacy risks. This episode unpacks the opportunities -- and dangers -- shaping the future of these life-changing drugs.

Featuring: Scott Roth, Chief Executive Officer, LegitScript

Gerard Olsen, Director of Research, LegitScript

In today’s episode, we'll cover…

  • The skyrocketing demand for GLP-1 medications and their influence on weight loss trends, including a 26% drop in bariatric surgeries
  • How telehealth and online pharmacies are reshaping access to GLP-1 drugs -- and the risks posed by rogue sellers and counterfeit products
  • The critical need for stronger regulatory enforcement and LegitScript's role in ensuring safety and transparency in the online healthcare market

To learn more about GLP-1 medications from all angles, check out our Pharma Life Sciences, Patient Engagement and Healthcare Payers sites.

To watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Metabolic bariatric surgery in the GLP-1 era (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825349)

Risks of online semaglutide without prescription (https://www.techtarget.com/pharmalifesciences/news/366609735/Study-uncovers-risks-of-buying-semaglutide-online)

FDA updates on GLP-1 compounding policies (https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize)

  continue reading

121 bölüm

Tüm bölümler

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi

Keşfederken bu şovu dinleyin
Çal